United States Kidney Cancer Diagnostics and Therapeutics Market Report 2017

February 2017 | 122 pages | ID: UC98D3306D1EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Kidney Cancer Diagnostics and Therapeutics

Revenue, means the sales value of Kidney Cancer Diagnostics and Therapeutics

This report studies sales (consumption) of Kidney Cancer Diagnostics and Therapeutics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• GlaxoSmithKline
• Bayer
• Pfizer
• Sanofi S.A
• Hoffmann La Roche
• Novartis
• Abbott Laboratories

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Transitional Cell Cancer
• Renal Cell Carcinoma
• Renal Sarcoma
• Others

Split by applications, this report focuses on sales, market share and growth rate of Kidney Cancer Diagnostics and Therapeutics in each application, can be divided into

• Biopsy
• Ct Scan
• Cystoscopy
• Intravenous Pyelogram
• Kidney Ultrasound

Contents

United States Kidney Cancer Diagnostics and Therapeutics Market Report 2017

1 KIDNEY CANCER DIAGNOSTICS AND THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Kidney Cancer Diagnostics and Therapeutics
1.2 Classification of Kidney Cancer Diagnostics and Therapeutics
  1.2.1 Transitional Cell Cancer
  1.2.2 Renal Cell Carcinoma
  1.2.3 Renal Sarcoma
  1.2.4 Others
1.3 Application of Kidney Cancer Diagnostics and Therapeutics
  1.3.1 Biopsy
  1.3.2 Ct Scan
  1.3.3 Cystoscopy
  1.3.4 Intravenous Pyelogram
  1.3.5 Kidney Ultrasound
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Kidney Cancer Diagnostics and Therapeutics (2012-2022)
  1.4.1 United States Kidney Cancer Diagnostics and Therapeutics Sales and Growth Rate (2012-2022)
  1.4.2 United States Kidney Cancer Diagnostics and Therapeutics Revenue and Growth Rate (2012-2022)

2 UNITED STATES KIDNEY CANCER DIAGNOSTICS AND THERAPEUTICS COMPETITION BY MANUFACTURERS

2.1 United States Kidney Cancer Diagnostics and Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Kidney Cancer Diagnostics and Therapeutics Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Kidney Cancer Diagnostics and Therapeutics Average Price by Manufactures (2015 and 2016)
2.4 Kidney Cancer Diagnostics and Therapeutics Market Competitive Situation and Trends
  2.4.1 Kidney Cancer Diagnostics and Therapeutics Market Concentration Rate
  2.4.2 Kidney Cancer Diagnostics and Therapeutics Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES KIDNEY CANCER DIAGNOSTICS AND THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Kidney Cancer Diagnostics and Therapeutics Sales and Market Share by States (2012-2017)
3.2 United States Kidney Cancer Diagnostics and Therapeutics Revenue and Market Share by States (2012-2017)
3.3 United States Kidney Cancer Diagnostics and Therapeutics Price by States (2012-2017)

4 UNITED STATES KIDNEY CANCER DIAGNOSTICS AND THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Kidney Cancer Diagnostics and Therapeutics Sales and Market Share by Type (2012-2017)
4.2 United States Kidney Cancer Diagnostics and Therapeutics Revenue and Market Share by Type (2012-2017)
4.3 United States Kidney Cancer Diagnostics and Therapeutics Price by Type (2012-2017)
4.4 United States Kidney Cancer Diagnostics and Therapeutics Sales Growth Rate by Type (2012-2017)

5 UNITED STATES KIDNEY CANCER DIAGNOSTICS AND THERAPEUTICS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Kidney Cancer Diagnostics and Therapeutics Sales and Market Share by Application (2012-2017)
5.2 United States Kidney Cancer Diagnostics and Therapeutics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES KIDNEY CANCER DIAGNOSTICS AND THERAPEUTICS MANUFACTURERS PROFILES/ANALYSIS

6.1 GlaxoSmithKline
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Kidney Cancer Diagnostics and Therapeutics Product Type, Application and Specification
    6.1.2.1 Transitional Cell Cancer
    6.1.2.2 Renal Cell Carcinoma
  6.1.3 GlaxoSmithKline Kidney Cancer Diagnostics and Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bayer
  6.2.2 Kidney Cancer Diagnostics and Therapeutics Product Type, Application and Specification
    6.2.2.1 Transitional Cell Cancer
    6.2.2.2 Renal Cell Carcinoma
  6.2.3 Bayer Kidney Cancer Diagnostics and Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.2 Kidney Cancer Diagnostics and Therapeutics Product Type, Application and Specification
    6.3.2.1 Transitional Cell Cancer
    6.3.2.2 Renal Cell Carcinoma
  6.3.3 Pfizer Kidney Cancer Diagnostics and Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanofi S.A
  6.4.2 Kidney Cancer Diagnostics and Therapeutics Product Type, Application and Specification
    6.4.2.1 Transitional Cell Cancer
    6.4.2.2 Renal Cell Carcinoma
  6.4.3 Sanofi S.A Kidney Cancer Diagnostics and Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Hoffmann La Roche
  6.5.2 Kidney Cancer Diagnostics and Therapeutics Product Type, Application and Specification
    6.5.2.1 Transitional Cell Cancer
    6.5.2.2 Renal Cell Carcinoma
  6.5.3 Hoffmann La Roche Kidney Cancer Diagnostics and Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Novartis
  6.6.2 Kidney Cancer Diagnostics and Therapeutics Product Type, Application and Specification
    6.6.2.1 Transitional Cell Cancer
    6.6.2.2 Renal Cell Carcinoma
  6.6.3 Novartis Kidney Cancer Diagnostics and Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Abbott Laboratories
  6.7.2 Kidney Cancer Diagnostics and Therapeutics Product Type, Application and Specification
    6.7.2.1 Transitional Cell Cancer
    6.7.2.2 Renal Cell Carcinoma
  6.7.3 Abbott Laboratories Kidney Cancer Diagnostics and Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 KIDNEY CANCER DIAGNOSTICS AND THERAPEUTICS MANUFACTURING COST ANALYSIS

7.1 Kidney Cancer Diagnostics and Therapeutics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Kidney Cancer Diagnostics and Therapeutics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Kidney Cancer Diagnostics and Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Kidney Cancer Diagnostics and Therapeutics Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES KIDNEY CANCER DIAGNOSTICS AND THERAPEUTICS MARKET FORECAST (2017-2022)

11.1 United States Kidney Cancer Diagnostics and Therapeutics Sales, Revenue Forecast (2017-2022)
11.2 United States Kidney Cancer Diagnostics and Therapeutics Sales Forecast by Type (2017-2022)
11.3 United States Kidney Cancer Diagnostics and Therapeutics Sales Forecast by Application (2017-2022)
11.4 Kidney Cancer Diagnostics and Therapeutics Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Kidney Cancer Diagnostics and Therapeutics
Table Classification of Kidney Cancer Diagnostics and Therapeutics
Figure United States Sales Market Share of Kidney Cancer Diagnostics and Therapeutics by Type in 2015
Figure Transitional Cell Cancer Picture
Figure Renal Cell Carcinoma Picture
Figure Renal Sarcoma Picture
Figure Others Picture
Table Application of Kidney Cancer Diagnostics and Therapeutics
Figure United States Sales Market Share of Kidney Cancer Diagnostics and Therapeutics by Application in 2015
Figure Biopsy Examples
Figure Ct Scan Examples
Figure Cystoscopy Examples
Figure Intravenous Pyelogram Examples
Figure Kidney Ultrasound Examples
Figure United States Kidney Cancer Diagnostics and Therapeutics Sales and Growth Rate (2012-2022)
Figure United States Kidney Cancer Diagnostics and Therapeutics Revenue and Growth Rate (2012-2022)
Table United States Kidney Cancer Diagnostics and Therapeutics Sales of Key Manufacturers (2015 and 2016)
Table United States Kidney Cancer Diagnostics and Therapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Kidney Cancer Diagnostics and Therapeutics Sales Share by Manufacturers
Figure 2016 Kidney Cancer Diagnostics and Therapeutics Sales Share by Manufacturers
Table United States Kidney Cancer Diagnostics and Therapeutics Revenue by Manufacturers (2015 and 2016)
Table United States Kidney Cancer Diagnostics and Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Kidney Cancer Diagnostics and Therapeutics Revenue Share by Manufacturers
Table 2016 United States Kidney Cancer Diagnostics and Therapeutics Revenue Share by Manufacturers
Table United States Market Kidney Cancer Diagnostics and Therapeutics Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Kidney Cancer Diagnostics and Therapeutics Average Price of Key Manufacturers in 2015
Figure Kidney Cancer Diagnostics and Therapeutics Market Share of Top 3 Manufacturers
Figure Kidney Cancer Diagnostics and Therapeutics Market Share of Top 5 Manufacturers
Table United States Kidney Cancer Diagnostics and Therapeutics Sales by States (2012-2017)
Table United States Kidney Cancer Diagnostics and Therapeutics Sales Share by States (2012-2017)
Figure United States Kidney Cancer Diagnostics and Therapeutics Sales Market Share by States in 2015
Table United States Kidney Cancer Diagnostics and Therapeutics Revenue and Market Share by States (2012-2017)
Table United States Kidney Cancer Diagnostics and Therapeutics Revenue Share by States (2012-2017)
Figure Revenue Market Share of Kidney Cancer Diagnostics and Therapeutics by States (2012-2017)
Table United States Kidney Cancer Diagnostics and Therapeutics Price by States (2012-2017)
Table United States Kidney Cancer Diagnostics and Therapeutics Sales by Type (2012-2017)
Table United States Kidney Cancer Diagnostics and Therapeutics Sales Share by Type (2012-2017)
Figure United States Kidney Cancer Diagnostics and Therapeutics Sales Market Share by Type in 2015
Table United States Kidney Cancer Diagnostics and Therapeutics Revenue and Market Share by Type (2012-2017)
Table United States Kidney Cancer Diagnostics and Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Kidney Cancer Diagnostics and Therapeutics by Type (2012-2017)
Table United States Kidney Cancer Diagnostics and Therapeutics Price by Type (2012-2017)
Figure United States Kidney Cancer Diagnostics and Therapeutics Sales Growth Rate by Type (2012-2017)
Table United States Kidney Cancer Diagnostics and Therapeutics Sales by Application (2012-2017)
Table United States Kidney Cancer Diagnostics and Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Kidney Cancer Diagnostics and Therapeutics Sales Market Share by Application in 2015
Table United States Kidney Cancer Diagnostics and Therapeutics Sales Growth Rate by Application (2012-2017)
Figure United States Kidney Cancer Diagnostics and Therapeutics Sales Growth Rate by Application (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Kidney Cancer Diagnostics and Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Kidney Cancer Diagnostics and Therapeutics Sales Market Share (2012-2017)
Table Bayer Basic Information List
Table Bayer Kidney Cancer Diagnostics and Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Kidney Cancer Diagnostics and Therapeutics Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Kidney Cancer Diagnostics and Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Kidney Cancer Diagnostics and Therapeutics Sales Market Share (2012-2017)
Table Sanofi S.A Basic Information List
Table Sanofi S.A Kidney Cancer Diagnostics and Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi S.A Kidney Cancer Diagnostics and Therapeutics Sales Market Share (2012-2017)
Table Hoffmann La Roche Basic Information List
Table Hoffmann La Roche Kidney Cancer Diagnostics and Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Hoffmann La Roche Kidney Cancer Diagnostics and Therapeutics Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Kidney Cancer Diagnostics and Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Kidney Cancer Diagnostics and Therapeutics Sales Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Kidney Cancer Diagnostics and Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories Kidney Cancer Diagnostics and Therapeutics Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Kidney Cancer Diagnostics and Therapeutics
Figure Manufacturing Process Analysis of Kidney Cancer Diagnostics and Therapeutics
Figure Kidney Cancer Diagnostics and Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Kidney Cancer Diagnostics and Therapeutics Major Manufacturers in 2015
Table Major Buyers of Kidney Cancer Diagnostics and Therapeutics
Table Distributors/Traders List
Figure United States Kidney Cancer Diagnostics and Therapeutics Production and Growth Rate Forecast (2017-2022)
Figure United States Kidney Cancer Diagnostics and Therapeutics Revenue and Growth Rate Forecast (2017-2022)
Table United States Kidney Cancer Diagnostics and Therapeutics Production Forecast by Type (2017-2022)
Table United States Kidney Cancer Diagnostics and Therapeutics Consumption Forecast by Application (2017-2022)
Table United States Kidney Cancer Diagnostics and Therapeutics Sales Forecast by States (2017-2022)
Table United States Kidney Cancer Diagnostics and Therapeutics Sales Share Forecast by States (2017-2022)